Search Results for: coronavirus

FedEx trucks sit outside the Juneau Fed Ex office on Nov. 25. (Dana Zigmund/Juneau Empire)
FedEx trucks sit outside the Juneau Fed Ex office on Nov. 25. (Dana Zigmund/Juneau Empire)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance for Tuesday, Nov. 23

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 23, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance for Monday, Nov. 22

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 22, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance for Friday, Nov. 19

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 19, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance for Thursday, Nov. 18

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 18, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance for Wednesday, Nov. 17

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 17, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
Michael S. Lockett / Juneau Empire
This August photo shows the cutter Midgett moored in Juneau. The U.S. Coast Guard, including the Midgett, is as of early November edging toward total vaccination.

Coast Guard edges toward full active-duty vaccination nationwide

Along with the other armed services, more than 90% of active duty members are fully vaccinated.

Michael S. Lockett / Juneau Empire
This August photo shows the cutter Midgett moored in Juneau. The U.S. Coast Guard, including the Midgett, is as of early November edging toward total vaccination.
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance for Tuesday, Nov. 16

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 16, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML

COVID at a Glance forMonday, Nov. 15

Numbers come from reports from the City and Borough of Juneau Emergency Operations Center and the Alaska Department of Health and Social Services, as well… Continue reading

  • Nov 15, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2, yellow, emerging from the surface of cells, blue/pink, cultured in the lab. Also known as 2019-nCoV, the virus causes COVID-19. THE CANADIAN PRESS/AP, NIAID-RML
A sign reading “Masks Required” lies on the ground near a softball field at Melvin Park in this May photo. The City and Borough of Juneau is lowering the community risk level for COVID-19, but masks remain required inside public spaces. (Ben Hohenstatt / Juneau Empire)

City lowers community risk level

While masks are still required in public places, some mitigation measures will immediately relax.

A sign reading “Masks Required” lies on the ground near a softball field at Melvin Park in this May photo. The City and Borough of Juneau is lowering the community risk level for COVID-19, but masks remain required inside public spaces. (Ben Hohenstatt / Juneau Empire)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Wednesday, Nov. 10

The latest local and state numbers.

  • Nov 10, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Tuesday, Nov.9

The latest local and state numbers.

  • Nov 9, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Monday, Nov. 8

The latest local and state numbers.

  • Nov 8, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Friday, Nov. 5

The latest local and state numbers.

  • Nov 5, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
Heidi Pearson is an associate professor of marine biology at the University of Alaska Southeast and lives in Juneau.  (Courtesy Photo)

Sustainable Alaska: Climate change, reality and hope

We all have the ability to reduce our own carbon footprint

Heidi Pearson is an associate professor of marine biology at the University of Alaska Southeast and lives in Juneau.  (Courtesy Photo)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Thursday, Nov. 4

The latest local and state numbers.

  • Nov 4, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Wednesday, Nov. 3

The latest local and state numbers.

  • Nov 3, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer)

US gives final clearance to COVID-19 shots for kids 5 to 11

By Lauran Neergaard and Mike Stobbe AP Medical Writers U.S. health officials on Tuesday gave the final signoff to Pfizer’s kid-size COVID-19 shot, a milestone… Continue reading

This photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. (Pfizer)
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)

COVID at a glance for Monday, Nov.1

The latest local and state numbers.

  • Nov 1, 2021
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the virus that causes COVID-19. Monoclonal antibodies may be a good treatment option for some people who test positive for the illness, according to state health officials. However, vaccination remains the best tool for limiting spread of COVID-19 and limiting hospitalizations. (NIAID-RML via AP, File)
This October 2021 photo provided by Pfizer shows boxes of kid-size doses of its COVID-19 vaccine. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP)
This October 2021 photo provided by Pfizer shows boxes of kid-size doses of its COVID-19 vaccine. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP)